FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

34959911000001103: Uvadex 200micrograms/10ml solution for blood fraction modification vials (Therakos (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Dec 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
143581000001111 Uvadex 200micrograms/10ml solution for blood fraction modification vials (Therakos (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
143591000001113 Uvadex 200micrograms/10ml solution for blood fraction modification vials (Therakos (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Uvadex 200micrograms/10ml solution for blood fraction modification vials (Therakos (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Uvadex 200micrograms/10ml solution for blood fraction modification vials (Therakos (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Uvadex 200micrograms/10ml solution for blood fraction modification vials (Therakos (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Uvadex 200micrograms/10ml solution for blood fraction modification vials (Therakos (UK) Ltd) Is a Methoxsalen 200micrograms/10ml solution for blood fraction modification vials true Inferred relationship Existential restriction modifier
Uvadex 200micrograms/10ml solution for blood fraction modification vials (Therakos (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Uvadex 200micrograms/10ml solution for blood fraction modification vials (Therakos (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Uvadex 200micrograms/10ml solution for blood fraction modification vials (Therakos (UK) Ltd) Has specific active ingredient Methoxsalen true Inferred relationship Existential restriction modifier
Uvadex 200micrograms/10ml solution for blood fraction modification vials (Therakos (UK) Ltd) Has dispensed dose form Solution for blood fraction modification true Inferred relationship Existential restriction modifier
Uvadex 200micrograms/10ml solution for blood fraction modification vials (Therakos (UK) Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Uvadex 200micrograms/10ml solution for blood fraction modification vials (Therakos (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Uvadex 200micrograms/10ml solution for blood fraction modification vials (Therakos (UK) Ltd) Has active ingredient Substance with immunomodulator mechanism of action true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Uvadex 200micrograms/10ml solution for blood fraction modification vials (Therakos (UK) Ltd) 12 vial Has AMP True Uvadex 200micrograms/10ml solution for blood fraction modification vials (Therakos (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start